Biochemical bone turnover markers are useful tools to assess changes in bone metabolism in marmosets

被引:5
|
作者
Angeliewa, A
Budde, M
Schlachter, M
Hoyle, NR
Bauss, F
机构
[1] Roche Diagnost GmbH, Pharma Res, Bone Metab, D-82377 Penzberg, Germany
[2] Univ Heidelberg, Inst Pharmacol & Toxicol, D-6800 Mannheim, Germany
[3] F Hoffmann La Roche & Co Ltd, Dept Pharma Res, Anim Husb, CH-4002 Basel, Switzerland
[4] Free Univ Berlin, Inst Anim Protect Behav & Lab Anim, D-1000 Berlin, Germany
[5] F Hoffmann La Roche & Co Ltd, Pharma Dev & Biostat, CH-4002 Basel, Switzerland
[6] Roche Vitamins Ltd, Basel, Switzerland
[7] Roche Diagnost GmbH, Bone metab & Anaemia, Cent Diagnost, D-82377 Penzberg, Germany
关键词
biochemical markers of bone turnover; bone formation; bone resorption; ibandronate; marmosets; osteoporosis; metabolic bone diseases;
D O I
10.1007/s00774-003-0469-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study was designed to investigate whether biochemical markers of bone resorption and formation could be determined in the serum and urine of marmosets (Callithrix jacchus), using standard laboratory chemistry methods and commercially available human kits. Consequently, the findings from this study will indicate whether the techniques and kits could serve as appropriate tools for assessing changes in bone turnover in this species. Two groups of animals (n = 12/group), consisting of a comparable number of young and old male and female marmosets, were given either isotonic saline or a single dose of the bisphosphonate ibandronate (0.1 mg/kg) s.c. in order to suppress bone turnover. Blood and urine were collected at baseline and 5 days after administration. Samples were analyzed for urinary (u) and serum (s) markers of bone formation (serum osteocalcin [sOC], serum N-terminal crosslinks of human pro-collagen type I [sP1NP]) and bone resorption (urinary pyridinoline [uPYD], urinary deoxypyridinoline [uDPD], serum C-terminal crosslinks of human collagen type I (C-telopeptide) [sCTX]), intact serum parathyroid hormone (iPTH) and urinary calcium and creatinine. Levels of all the markers of bone resorption and formation decreased during the study period. As expected, the bone formation markers decreased slightly less relative to the resorption markers. The most sensitive markers were sCTX (-33%; P less than or equal to 0.001) for bone resorption, and sP1NP (-3%; P less than or equal to 0.05) for bone formation. Serum PTH levels increased by 8% (P less than or equal to 0.05), demonstrating a physiological reaction to prevent changes in serum calcium. Although not all variables reached statistical significance within the tested interval, the applied methods and kits were considered suitable for evaluating bone turnover changes in marmosets. Thus, these methods and kits can be utilized not only during the course of pharmacological investigations but also as additional tools to assess the overall bone health of this species.
引用
收藏
页码:192 / 197
页数:6
相关论文
共 50 条
  • [41] Biochemical markers of bone turnover in aseptic loosening in hip arthroplasty
    Nikolaus A. Streich
    Tobias Gotterbarm
    Martin Jung
    Ulrich Schneider
    Christian Heisel
    International Orthopaedics, 2009, 33 : 77 - 82
  • [42] Bone turnover markers
    Coates, Penelope
    AUSTRALIAN FAMILY PHYSICIAN, 2013, 42 (05) : 285 - 287
  • [43] Guidelines on the use of biochemical markers of bone turnover in osteoporosis (2001)
    Yoshiki Nishizawa
    Toshitaka Nakamura
    Hiroaki Ohata
    Kazuhiro Kushida
    Itsuo Gorai
    Masataka Shiraki
    Masao Fukunaga
    Takayuki Hosoi
    Takami Miki
    Kiyoshi Nakatsuka
    Masakazu Miura
    Journal of Bone and Mineral Metabolism, 2001, 19 : 338 - 344
  • [44] Biochemical markers of bone turnover: preanalytical variability and recommendations for use
    Garnero, P
    Bianchi, F
    Carlier, MC
    Genty, V
    Jacob, N
    Kamel, S
    Kindermans, C
    Plouvier, E
    Pressac, M
    Souberbielle, JC
    ANNALES DE BIOLOGIE CLINIQUE, 2000, 58 (06) : 683 - 704
  • [45] Guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004)
    Yoshiki Nishizawa
    Toshitaka Nakamura
    Hiroaki Ohta
    Kazuhiro Kushida
    Itsuo Gorai
    Masataka Shiraki
    Masao Fukunaga
    Takayuki Hosoi
    Takami Miki
    Osamu Chaki
    Schoichi Ichimura
    Kiyoshi Nakatsuka
    Masakazu Miura
    Journal of Bone and Mineral Metabolism, 2005, 23 : 97 - 104
  • [46] Biochemical markers of bone turnover in benign paroxysmal positional vertigo
    Lee, Sun Bin
    Lee, Chang Ho
    Kim, Young Ju
    Kim, Hyoung-Mi
    PLOS ONE, 2017, 12 (05):
  • [47] Biochemical markers of bone turnover: Recent data and avenues for the future
    Garnero, P
    REVUE DU RHUMATISME, 1999, 66 (11): : 538 - 542
  • [48] Guidelines on the use of biochemical markers of bone turnover in osteoporosis (2001)
    Nishizawa, Y
    Nakamura, T
    Ohata, H
    Kushida, K
    Gorai, I
    Shiraki, M
    Fukunaga, M
    Hosoi, T
    Miki, T
    Nakatsuka, K
    Miura, M
    Japan Osteoporosis Soc
    JOURNAL OF BONE AND MINERAL METABOLISM, 2001, 19 (06) : 338 - 344
  • [49] Guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004)
    Nishizawa, Y
    Nakamura, T
    Ohta, H
    Kushida, K
    Gorai, I
    Shiraki, M
    Fukunaga, M
    Hosoi, T
    Miki, T
    Chaki, O
    Ichimura, S
    Nakatsuka, K
    Miura, M
    JOURNAL OF BONE AND MINERAL METABOLISM, 2005, 23 (02) : 97 - 104
  • [50] Use of biochemical markers of bone turnover in the management of postmenopausal osteoporosis
    Camacho, Pauline M.
    Lopez, Norma A.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2008, 46 (10) : 1345 - 1357